secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2022-11-17T23:59:59+00:00
Accession:  0001104659-22-119905
Event type: other
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aprea Therapeutics shareholders approve reverse stock split at ratio of 1:3 to 1:20
--------------------------------------------------------------------------------

- Proposal 1 passed with 36,030,837 votes for, 2,418,669 against, 450,037 abstentions.
- Board can set exact ratio within 1:3 to 1:20 range before February 28, 2023, or abandon split.
- Proposal 2 (adjournment if needed) also approved, 36,441,099 for, 1,892,580 against.
- No broker non-votes on either proposal; all shares voted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000110465922119905/0001104659-22-119905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000110465922119905/tm2230787d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-119905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer